$0.00
(0.00%
) Quote detailsUSD
$0.00
(0.00%
)At Close (As of Nov 28, 2025)
$68.21M
Market Cap
-
P/E Ratio
-6.87
EPS
$21.41
52 Week High
$2.31
52 Week Low
HEALTHCARE
Sector
Sector: HEALTHCARE
Industry: BIOTECHNOLOGY
Coeptis Therapeutics Inc. is a biopharmaceutical company based in Wexford, Pennsylvania, focused on the development and commercialization of pioneering cancer therapies that blend branded and generic pharmaceuticals with advanced cell therapy platforms. With a steadfast commitment to addressing unmet medical needs in the oncology space, Coeptis aims to enhance treatment outcomes and improve the quality of life for cancer patients. The company’s robust research and development initiatives position it to deliver innovative solutions within the cancer therapeutics market, establishing it as a significant player in the biopharmaceutical sector.
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL
LPTX
KTTA
NVDA
HBI
TLRY
INTC
BITF
IPG
BYND
CLSK
ADAP
ASST
PLUG
SNAP
BIYA
AAL
TSLA
CIFR
MARA
WULF
NIO
F
MTSR
SOFI
VALE
GOOGL
BTBT
ADTX
DVLT
GRAB
PFE
DNN
IBRX
RIOT
CAN
AG
WBD
APLD
GOOG
IREN
RIG
BAC
AMD
SMR
TMC
PLTR
CDE
ITUB
AGNC
T
AMC
VHAI
NVO
MSTR
NFLX
SAND
MSFT
HBAN
HL